Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Assets (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Non-Current Assets data on record, last reported at $7.9 million in Q3 2021.

  • For Q3 2021, Non-Current Assets rose 22.11% year-over-year to $7.9 million; the TTM value through Sep 2021 reached $26.6 million, down 11.79%, while the annual FY2020 figure was $6.0 million, 32.02% down from the prior year.
  • Non-Current Assets reached $7.9 million in Q3 2021 per COGT's latest filing, up from $7.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $11.4 million in Q1 2019 and bottomed at $4.9 million in Q4 2018.
  • Average Non-Current Assets over 4 years is $7.5 million, with a median of $7.2 million recorded in 2021.
  • Peak YoY movement for Non-Current Assets: surged 90.84% in 2019, then tumbled 34.85% in 2020.
  • A 4-year view of Non-Current Assets shows it stood at $4.9 million in 2018, then soared by 79.33% to $8.8 million in 2019, then tumbled by 32.02% to $6.0 million in 2020, then soared by 31.26% to $7.9 million in 2021.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $7.9 million in Q3 2021, $7.2 million in Q2 2021, and $5.5 million in Q1 2021.